Literature DB >> 6218121

Complementary activity of mezlocillin and the combination of amoxicillin with clavulanic acid on Enterobacteriaceae.

C Roy, A Foz, M Tirado, C Fuster, C Segura.   

Abstract

The MICs of amoxicillin, mezlocillin and BRL 25,000, a combination of two parts amoxicillin and one part clavulanic acid (2AM + 1CA), were measured for 331 Enterobacteriaceae strains which produced beta-lactamases as demonstrated by nitrocefin. The MIC values for mezlocillin and the combination 2AM + 1CA were very similar for the total number of the strains investigated. When investigated separately according to the bacterial species, three different sensitivity groups were established for the above-mentioned preparations: 1) species with the same or similar sensitivity to mezlocillin and 2AM + 1CA (Escherichia coli and Shigella spp., amoxicillin-resistant strains); 2) species which were more sensitive to mezlocillin than to the combination 2AM + 1CA (Citrobacter spp., Enterobacter cloacae, Serratia spp. and indole-positive Proteus as well as strains of E. coli and Shigella spp. which produce a cephalosporinase and are sensitive to amoxicillin); 3) species which are more sensitive to 2AM + 1CA than to mezlocillin (amoxicillin-resistant Salmonella spp., Proteus mirabilis and Klebsiella pneumoniae). This complementary activity of mezlocillin and 2AM + 1CA against Enterobacteriaceae depended on the beta-lactamases produced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218121     DOI: 10.1007/bf01640685

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.

Authors:  R Wise; A P Gillett; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

2.  [Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)].

Authors:  C Roy; C Segura; C Fuster; M Tirado; A Foz
Journal:  Med Clin (Barc)       Date:  1982-05-01       Impact factor: 1.725

3.  [In vitro activity of BRL 25.000 (amoxycillin plus clavulanic acid) against Enterobacteriaceae betalactamase producers (author's transl)].

Authors:  C Roy; C Segura; M Tirado; C Fuster; A Foz
Journal:  Med Clin (Barc)       Date:  1982 Mar 1-15       Impact factor: 1.725

4.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  New naturally occurring beta-lactam antibiotics and related compounds.

Authors:  A G Brown
Journal:  J Antimicrob Chemother       Date:  1981-01       Impact factor: 5.790

6.  [Studies on antibacterial activity of cephotaxime (HR 756), a new antibiotic of the cephalosporin group (author's transl)].

Authors:  A Foz; C Roy; C Segura; C Fuster; M Tirado
Journal:  Med Clin (Barc)       Date:  1980-11-25       Impact factor: 1.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.